CID 167312535

91079-38-8

Structural Information

Molecular Formula
C30H44N2O5S
SMILES
CC1CCC23CCC(=O)C2C1(C(CC(C(C3C)O)(C)C=C)OC(=O)CSC4=NC(=CC(=N4)OC(C)C)C)C
InChI
InChI=1S/C30H44N2O5S/c1-9-28(7)15-22(37-24(34)16-38-27-31-19(5)14-23(32-27)36-17(2)3)29(8)18(4)10-12-30(20(6)26(28)35)13-11-21(33)25(29)30/h9,14,17-18,20,22,25-26,35H,1,10-13,15-16H2,2-8H3
InChIKey
LLDFPCVMAZVYJT-UHFFFAOYSA-N
Compound name
(4-ethenyl-3-hydroxy-2,4,7,14-tetramethyl-9-oxo-6-tricyclo[5.4.3.01,8]tetradecanyl) 2-(4-methyl-6-propan-2-yloxypyrimidin-2-yl)sulfanylacetate
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

0
References

2
Patents

544.2971 Da
Monoisotopic Mass

6.6
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 545.30438 224.2
[M+Na]+ 567.28632 227.4
[M-H]- 543.28982 225.2
[M+NH4]+ 562.33092 229.1
[M+K]+ 583.26026 225.9
[M+H-H2O]+ 527.29436 219.3
[M+HCOO]- 589.29530 223.5
[M+CH3COO]- 603.31095 251.5
[M+Na-2H]- 565.27177 215.7
[M]+ 544.29655 224.9
[M]- 544.29765 224.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

No literature data available for this compound.

Patent stripe

patents stripe